| Period Ending |
Mar 31, 2015 |
Dec 31, 2014 |
Sep 30, 2014 |
Mar 31, 2014 |
| Total Revenue |
57 |
97 |
14 |
49 |
| Cost of Revenue |
14 |
66 |
(15) |
– |
|
| Gross Profit |
43 |
31 |
29 |
49 |
|
|
Operating Expenses |
|
Research Development |
– |
– |
– |
– |
|
Selling General and Administrative |
528 |
735 |
1,342 |
961 |
|
Non Recurring |
– |
– |
– |
– |
|
Others |
9 |
47 |
13 |
3 |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
| Operating Income or Loss |
(494) |
(752) |
(1,325) |
(915) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
(265) |
(2,962) |
(346) |
(953) |
|
Earnings Before Interest And Taxes |
(759) |
(3,714) |
(1,671) |
(1,869) |
|
Interest Expense |
69 |
41 |
76 |
50 |
|
Income Before Tax |
(828) |
(3,755) |
(1,747) |
(1,919) |
|
Income Tax Expense |
– |
– |
– |
– |
|
Minority Interest |
– |
– |
– |
– |
|
|
|
Net Income From Continuing Ops |
(828) |
(3,755) |
(1,747) |
(1,919) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
2 |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
| Net Income |
(828) |
(3,755) |
(1,747) |
(1,917) |
| Preferred Stock And Other Adjustments |
– |
– |
– |
– |
|
| Net Income Applicable To Common Shares |
(828) |
(3,755) |
(1,747) |
(1,917) |
|